Virtus ETF Advisers’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-560
| Closed | -$40.2K | – | 476 |
|
|
2024
Q1 | $40.2K | Sell |
560
-38
| -6% | -$2.73K | 0.02% | 420 |
|
|
2023
Q4 | $119K | Buy |
598
+12
| +2% | +$2.39K | 0.08% | 322 |
|
|
2023
Q3 | $78K | Sell |
586
-58
| -9% | -$7.72K | 0.05% | 365 |
|
|
2023
Q2 | $96.4K | Sell |
644
-44
| -6% | -$6.58K | 0.06% | 402 |
|
|
2023
Q1 | $101K | Sell |
688
-265
| -28% | -$38.9K | 0.06% | 336 |
|
|
2022
Q4 | $151K | Buy |
953
+76
| +9% | +$12K | 0.08% | 343 |
|
|
2022
Q3 | $169K | Buy |
877
+6
| +0.7% | +$1.16K | 0.07% | 337 |
|
|
2022
Q2 | $127K | Buy |
871
+236
| +37% | +$34.4K | 0.05% | 364 |
|
|
2022
Q1 | $112K | Sell |
635
-39
| -6% | -$6.88K | 0.05% | 284 |
|
|
2021
Q4 | $198K | Buy |
674
+10
| +2% | +$2.94K | 0.07% | 211 |
|
|
2021
Q3 | $165K | Sell |
664
-35
| -5% | -$8.7K | 0.07% | 319 |
|
|
2021
Q2 | $178K | Sell |
699
-849
| -55% | -$216K | 0.07% | 387 |
|
|
2021
Q1 | $275K | Buy |
1,548
+29
| +2% | +$5.15K | 0.12% | 260 |
|
|
2020
Q4 | $240K | Sell |
1,519
-271
| -15% | -$42.8K | 0.1% | 325 |
|
|
2020
Q3 | $461K | Sell |
1,790
-244
| -12% | -$62.8K | 0.24% | 145 |
|
|
2020
Q2 | $472K | Buy |
+2,034
| New | +$472K | 0.22% | 157 |
|